LANTHEUS HOLDINGS INC (LNTH) Stock Fundamental Analysis
NASDAQ:LNTH - Nasdaq - US5165441032 - Common Stock - Currency: USD
We assign a fundamental rating of 8 out of 10 to LNTH. LNTH was compared to 190 industry peers in the Health Care Equipment & Supplies industry. LNTH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. LNTH is growing strongly while it is still valued neutral. This is a good combination! With these ratings, LNTH could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
In the past year LNTH was profitable.
In the past year LNTH had a positive cash flow from operations.
In multiple years LNTH reported negative net income over the last 5 years.
LNTH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 15.78%, LNTH belongs to the best of the industry, outperforming 95.79% of the companies in the same industry.
The Return On Equity of LNTH (28.72%) is better than 97.89% of its industry peers.
With an excellent Return On Invested Capital value of 19.59%, LNTH belongs to the best of the industry, outperforming 98.95% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for LNTH is significantly above the industry average of 7.68%.
The 3 year average ROIC (16.25%) for LNTH is below the current ROIC(19.59%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 15.78% | ||
| ROE | 28.72% | ||
| ROIC | 19.59% |
ROA(3y)12.56%
ROA(5y)5.58%
ROE(3y)25.01%
ROE(5y)11.41%
ROIC(3y)16.25%
ROIC(5y)N/A
1.3 Margins
LNTH has a better Profit Margin (20.37%) than 94.21% of its industry peers.
In the last couple of years the Profit Margin of LNTH has grown nicely.
Looking at the Operating Margin, with a value of 29.24%, LNTH belongs to the top of the industry, outperforming 97.89% of the companies in the same industry.
LNTH's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 64.43%, LNTH is in the better half of the industry, outperforming 65.79% of the companies in the same industry.
In the last couple of years the Gross Margin of LNTH has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.24% | ||
| PM (TTM) | 20.37% | ||
| GM | 64.43% |
OM growth 3YN/A
OM growth 5Y14.46%
PM growth 3YN/A
PM growth 5Y17.41%
GM growth 3Y13.43%
GM growth 5Y5.06%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), LNTH is creating value.
LNTH has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, LNTH has more shares outstanding
The debt/assets ratio for LNTH has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 7.16 indicates that LNTH is not in any danger for bankruptcy at the moment.
LNTH has a better Altman-Z score (7.16) than 87.89% of its industry peers.
LNTH has a debt to FCF ratio of 1.22. This is a very positive value and a sign of high solvency as it would only need 1.22 years to pay back of all of its debts.
LNTH has a better Debt to FCF ratio (1.22) than 91.58% of its industry peers.
A Debt/Equity ratio of 0.52 indicates that LNTH is somewhat dependend on debt financing.
The Debt to Equity ratio of LNTH (0.52) is worse than 62.11% of its industry peers.
Even though the debt/equity ratio score it not favorable for LNTH, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 1.22 | ||
| Altman-Z | 7.16 |
ROIC/WACC2.27
WACC8.65%
2.3 Liquidity
LNTH has a Current Ratio of 5.52. This indicates that LNTH is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.52, LNTH belongs to the top of the industry, outperforming 80.53% of the companies in the same industry.
A Quick Ratio of 5.23 indicates that LNTH has no problem at all paying its short term obligations.
LNTH has a better Quick ratio (5.23) than 82.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.52 | ||
| Quick Ratio | 5.23 |
3. Growth
3.1 Past
LNTH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.83%, which is quite good.
Measured over the past years, LNTH shows a very strong growth in Earnings Per Share. The EPS has been growing by 42.10% on average per year.
Looking at the last year, LNTH shows a quite strong growth in Revenue. The Revenue has grown by 18.32% in the last year.
The Revenue has been growing by 34.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)8.83%
EPS 3Y140.07%
EPS 5Y42.1%
EPS Q2Q%-9.14%
Revenue 1Y (TTM)18.32%
Revenue growth 3Y53.37%
Revenue growth 5Y34.59%
Sales Q2Q%10.48%
3.2 Future
Based on estimates for the next years, LNTH will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.23% on average per year.
LNTH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.86% yearly.
EPS Next Y5.84%
EPS Next 2Y9.4%
EPS Next 3Y11.01%
EPS Next 5Y9.23%
Revenue Next Year4.65%
Revenue Next 2Y8.39%
Revenue Next 3Y10.79%
Revenue Next 5Y8.86%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
LNTH is valuated correctly with a Price/Earnings ratio of 14.94.
Based on the Price/Earnings ratio, LNTH is valued cheaper than 86.32% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 28.29. LNTH is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 14.12, the valuation of LNTH can be described as correct.
Based on the Price/Forward Earnings ratio, LNTH is valued cheaply inside the industry as 84.74% of the companies are valued more expensively.
LNTH's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.08.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.94 | ||
| Fwd PE | 14.12 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LNTH is valued cheaply inside the industry as 83.68% of the companies are valued more expensively.
90.00% of the companies in the same industry are more expensive than LNTH, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.92 | ||
| EV/EBITDA | 12.84 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates LNTH does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of LNTH may justify a higher PE ratio.
PEG (NY)2.56
PEG (5Y)0.35
EPS Next 2Y9.4%
EPS Next 3Y11.01%
5. Dividend
5.1 Amount
LNTH does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
101.32
+0.8 (+0.8%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners110.89%
Inst Owner Change0%
Ins Owners1.47%
Ins Owner Change4.96%
Market Cap6.94B
Analysts82.11
Price Target137.07 (35.28%)
Short Float %9.57%
Short Ratio6.8
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)4.34%
Min EPS beat(2)1.61%
Max EPS beat(2)7.07%
EPS beat(4)3
Avg EPS beat(4)3.11%
Min EPS beat(4)-3.57%
Max EPS beat(4)7.34%
EPS beat(8)7
Avg EPS beat(8)8.66%
EPS beat(12)11
Avg EPS beat(12)21.37%
EPS beat(16)15
Avg EPS beat(16)63.31%
Revenue beat(2)1
Avg Revenue beat(2)1.02%
Min Revenue beat(2)-0.1%
Max Revenue beat(2)2.13%
Revenue beat(4)3
Avg Revenue beat(4)1.81%
Min Revenue beat(4)-0.1%
Max Revenue beat(4)4.1%
Revenue beat(8)6
Avg Revenue beat(8)2.08%
Revenue beat(12)10
Avg Revenue beat(12)4.68%
Revenue beat(16)14
Avg Revenue beat(16)5.09%
PT rev (1m)-0.29%
PT rev (3m)-0.23%
EPS NQ rev (1m)-0.01%
EPS NQ rev (3m)7.62%
EPS NY rev (1m)1.18%
EPS NY rev (3m)2.33%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)-0.44%
Revenue NY rev (1m)-0.8%
Revenue NY rev (3m)-0.55%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.94 | ||
| Fwd PE | 14.12 | ||
| P/S | 4.52 | ||
| P/FCF | 14.92 | ||
| P/OCF | 12.74 | ||
| P/B | 6.38 | ||
| P/tB | 8.02 | ||
| EV/EBITDA | 12.84 |
EPS(TTM)6.78
EY6.69%
EPS(NY)7.18
Fwd EY7.08%
FCF(TTM)6.79
FCFY6.7%
OCF(TTM)7.95
OCFY7.85%
SpS22.4
BVpS15.89
TBVpS12.63
PEG (NY)2.56
PEG (5Y)0.35
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 15.78% | ||
| ROE | 28.72% | ||
| ROCE | 25.78% | ||
| ROIC | 19.59% | ||
| ROICexc | 41.22% | ||
| ROICexgc | 56.43% | ||
| OM | 29.24% | ||
| PM (TTM) | 20.37% | ||
| GM | 64.43% | ||
| FCFM | 30.32% |
ROA(3y)12.56%
ROA(5y)5.58%
ROE(3y)25.01%
ROE(5y)11.41%
ROIC(3y)16.25%
ROIC(5y)N/A
ROICexc(3y)32.43%
ROICexc(5y)N/A
ROICexgc(3y)46.23%
ROICexgc(5y)N/A
ROCE(3y)21.38%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y26.32%
ROICexc growth 3YN/A
ROICexc growth 5Y20.97%
OM growth 3YN/A
OM growth 5Y14.46%
PM growth 3YN/A
PM growth 5Y17.41%
GM growth 3Y13.43%
GM growth 5Y5.06%
F-Score6
Asset Turnover0.77
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 1.22 | ||
| Debt/EBITDA | 1.1 | ||
| Cap/Depr | 123.21% | ||
| Cap/Sales | 5.19% | ||
| Interest Coverage | 29.72 | ||
| Cash Conversion | 106.15% | ||
| Profit Quality | 148.87% | ||
| Current Ratio | 5.52 | ||
| Quick Ratio | 5.23 | ||
| Altman-Z | 7.16 |
F-Score6
WACC8.65%
ROIC/WACC2.27
Cap/Depr(3y)104.83%
Cap/Depr(5y)78.74%
Cap/Sales(3y)4.75%
Cap/Sales(5y)4.15%
Profit Quality(3y)383.97%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.83%
EPS 3Y140.07%
EPS 5Y42.1%
EPS Q2Q%-9.14%
EPS Next Y5.84%
EPS Next 2Y9.4%
EPS Next 3Y11.01%
EPS Next 5Y9.23%
Revenue 1Y (TTM)18.32%
Revenue growth 3Y53.37%
Revenue growth 5Y34.59%
Sales Q2Q%10.48%
Revenue Next Year4.65%
Revenue Next 2Y8.39%
Revenue Next 3Y10.79%
Revenue Next 5Y8.86%
EBIT growth 1Y-9.69%
EBIT growth 3YN/A
EBIT growth 5Y54.05%
EBIT Next Year12.63%
EBIT Next 3Y13.72%
EBIT Next 5YN/A
FCF growth 1Y118%
FCF growth 3Y123.25%
FCF growth 5Y51.49%
OCF growth 1Y78.45%
OCF growth 3Y116.21%
OCF growth 5Y46.62%